Randomised trial improved gingival thickness and ridge width in patients with alveolar defects, suggesting I-PRF enhances bone regeneration.
Purpose: This study aimed to evaluate the effect of recurrent injectable-platelet-rich-fibrin (I-PRF) in conjunction with autogenous bone on gingival thickness (GT), alveolar width, and volumetric bone changes during maxillary alveolar augmentation using cone-beam computer tomograms (CBCT). Materials and Methods: Twenty-eight patients with alveolar defects require bone augmentation. Two patient groups were chosen at random. Group I consisted of 14 patients who received only cortical ramus autogenous bone harvest (control group). Fourteen patients in Group II received autogenous bone grafting in addition to repeated I-PRF. To examine the alveolar ridge width, CBCT was performed before, immediately following, and at 6 and 9 months. Three-dimensional volumetric changes in bone were carried out using the sequence of CBCT image segmentation and 3D superimposition analysis. Results: At 9 months of follow-up, Group II showed significant improvements in GT compared to Group I. Radiographic evaluation of ridge width at 9 months revealed a significant mean increase in ridge width in Group II. There is a notable variation in bone volume between the two groups. Group II’s volumetric measurements increased significantly when compared to preoperative readings at 9 months ( P = .02). Conclusions: Repeated injections of I-PRF improve GT and bone growth. Additionally, it maintains the autogenous bone graft’s integrity throughout the early healing phase.
No takes yet. Share an insight, caveat, or question.
Ahmed et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: